The mechanisms of action of many common antiepileptics are currently not fully understood. These drugs have a narrow therapeutic window with some severe side effects. Here, we are setting up a pipeline to study the distribution of CNS-targeting drugs non-invasively with MRI, using deuterium (2H) labelling and deuterium magnetic resonance spectroscopy.
This abstract and the presentation materials are available to members only; a login is required.